Marrone Bio Innovations

Marrone Bio Innovations EV/EBITDA

Delisted

The EV/EBITDA (Enterprise Value to EBITDA) of Marrone Bio Innovations (MBII) as of Nov 18, 2026 is -10.68. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 113.52 — a change of -109.41% (lower).

EV/EBITDA

-10.68

YoY

-109.41%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Marrone Bio Innovations is 2021 -10.68 . EV/EBITDA (Enterprise Value to EBITDA) of Marrone Bio Innovations was 2020 113.52 . It decreases by -109.41% lower compared to the previous year.

The Marrone Bio Innovations EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2014
-2.73 USD
Jan 1, 2015
-3.75 USD
Jan 1, 2016
-8.12 USD
Jan 1, 2017
-8.99 USD
Jan 1, 2018
-8.40 USD
Jan 1, 2019
-4.55 USD
Jan 1, 2020
113.52 USD
Jan 1, 2021
-10.68 USD
The Marrone Bio Innovations EV/EBITDA history
YEAREV/EBITDAYoY
-10.68-109.41%
113.52-2,595.25%
-4.55-45.86%
-8.40-6.52%
-8.99+10.68%
-8.12+116.82%
-3.75+36.99%
-2.73—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Marrone Bio Innovations Stock analysis

What does Marrone Bio Innovations do? Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility. Marrone Bio Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Marrone Bio Innovations stock

EV/EBITDA (Enterprise Value to EBITDA) of Marrone Bio Innovations is -10.68 in 2021.

EV/EBITDA (Enterprise Value to EBITDA) of Marrone Bio Innovations changed from 113.52 to -10.68, representing a -109.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Marrone Bio Innovations since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Marrone Bio Innovations with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Marrone Bio Innovations

All Key Metrics — Marrone Bio Innovations